Stephens & Co. has initiated coverage on Oscar Health Inc (OSCR), assigning the company an Equal-Weight rating. This marks the firm's first assessment of Oscar Health's investment potential, grounded in a thorough analysis of its business model, industry dynamics, and growth prospects.
Oscar Health, headquartered in New York City, operates within the insurance industry, leveraging a technology platform to serve its customers. The company employs approximately 2,400 full-time staff and offers health plans primarily in the individual market, including policies available through health insurance marketplaces established by the Affordable Care Act.
As of December 10, 2025, Oscar Health's current share price stands at $16.32, with a market capitalization of $3.6 billion. The firm reported an earnings per share (EPS) of -1.14 for the trailing twelve months.
Upcoming earnings are scheduled for August 4, 2026, with an estimated EPS of -0.03 and revenue of $3.2 billion. The most recent earnings performance showed a Q3 2025 EPS of -0.53, exceeding estimates by 6.6%. Analyst consensus as of December 1, 2025, indicates a Hold rating, with 1 Strong Buy, 2 Buy, 5 Hold, 5 Sell, and 3 Strong Sell recommendations from a total of 16 analysts.
Analyst ratings and price targets provide insights based on research and financial models. However, they are contingent on various assumptions that may not materialize. Investment decisions should consider a range of factors, including company fundamentals and market trends, rather than relying solely on analyst views. Ratings can evolve as new information arises, reflecting the dynamic nature of market evaluations.